Autologous stem cell transplantation for adult acute myelocytic leukemia in first remission-Better outcomes after busulfan and melphalan compared with busulfan and cyclophosphamide: A retrospective study from the Acute Leukemia Working Party of the Europe-Reference-Cited by-同舟云学术

Autologous stem cell transplantation for adult acute myelocytic leukemia in first remission-Better outcomes after busulfan and melphalan compared with busulfan and cyclophosphamide: A retrospective study from the Acute Leukemia Working Party of the Europe

Published:2016-12-01 Issue:5 Volume:123 Page:824-831
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Gorin Norbert-Claude¹²,Labopin Myriam²,Czerw Tomasz³,Pabst Thomas⁴,Blaise Didier⁵,Dumas Pierre-Yves⁶,Nemet Damir⁷,Arcese William⁸,Trisolini Silvia Maria⁹,Wu Depei¹⁰,Huynh Anne¹¹,Zuckerman Tsila¹²¹³,Meijer Ellen¹⁴,Cagirgan Seckin¹⁵,Cornelissen Jan¹⁶,Houhou Mohamed¹,Polge Emmanuelle¹,Mohty Mohamad¹,Nagler Arnon²¹⁷

Affiliation:

1. Department of Hematology and Cellular Therapy, European Society for Blood and Marrow Transplantation (EBMT), National Institute of Health and Medical Research (INSERM) Unit 938, St. Antoine Public Assistance Hospital; Pierre and Marie Curie University; Paris France

2. EBMT Office, INSERM Unit 938, St. Antoine Public Assistance Hospital, Pierre and Marie Curie University; Paris France

3. Department of Bone Marrow Transplantation and Oncohematology; Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch; Gliwice Poland

4. Department of Oncology; University Hospital Bern; Bern Switzerland

5. Aix Marseille University; CNRS, INSERM, CRCM, Institut Paoli-calmettes; Marseille France

6. Department of Hematology, Haut-Leveque Hospital; University Hospital Center of Bordeaux; Pessac France

7. Department of Hematology; University Hospital Center Rebro; Zagreb Croatia

8. Stem Cell Transplant Unit, Rome Transplant Network, Tor Vergata University Polyclinic; Tor Vergata University; Rome Italy

9. Department of Cellular Biotechnology and Hematology; Louisiana Sapienza University; Rome Italy

10. Department of Hematology; First Affiliated Hospital of Soochow University; Suzhou Jiangsu China

11. The Cancer University Institute of Toulouse Oncopole; Toulouse France

12. Department of Hematology and Bone Marrow Transplantation; Rambam Medical Center; Haifa Israel

13. Technion-Israel Institute of Technology; Haifa Israel

14. Department of Hematology; Free University Medical Center; Amsterdam the Netherlands

15. Department of Hematology; Ege University Medical School; Izmir Turkey

16. Daniel den Hoed Cancer Center, Erasmus Medical Center; Rotterdam the Netherlands

17. Department of Hematology and Bone Marrow Transplantation; Chaim Sheba Medical Center; Tel Hashomer Israel

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.30400/fullpdf

Reference33 articles.

1. Long-term follow-up of patients with acute myeloid leukemia surviving and free of disease recurrence at least 2 years after autologous hematopoietic stem cell transplantation: a report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation [published online ahead of print 28 March 2016];Czerw;Cancer,2016

2. Impact of different post-remission strategies on quality of life in patients with acute myeloid leukemia;Messerer;Haematologica,2008

3. Prevalence and predictors of chronic health conditions after hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study;Sun;Blood,2010

4. Adverse impact of bone marrow transplantation on quality of life in acute myeloid leukaemia patients; analysis of the UK Medical Research Council AML 10 Trial;Watson;Eur J Cancer,2004

5. Preliminary results of high-dose busulfan and cyclophosphamide with syngeneic or autologous bone marrow rescue;Lu;Cancer Treat Rep,1984

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Etoposide plus cytarabine versus cyclophosphamide or melphalan in busulfan-based preparative regimens for autologous stem cell transplantation in adults with acute myeloid leukemia in first complete remission: a study from the Acute Leukemia Working Party of the EBMT;Bone Marrow Transplantation;2023-08-08

2. Low Incidence of Relapse with a Moderate Conditioning Regimen of Fludarabine, Busulfan, and Melphalan for Patients with Myeloid Malignancies: A Single-Center Analysis of 100 Patients;Transplantation and Cellular Therapy;2023-08

3. Etoposide plus cytarabine versus cyclophosphamide or melphalan in busulfan-based preparative regimens for autologous stem cell transplantation in adults with acute myeloid leukemia in first complete remission: A study from the Acute Leukemia Working Party of the EBMT;2023-06-05

4. Stem Cell Transplant for Acute Myeloid Leukemia;Basics of Hematopoietic Stem Cell Transplant;2023

5. Double alkylators based conditioning reduced the relapse rate after allogeneic peripheral blood stem cell transplantation in adult patients with myeloid malignancies: a single arm phase II study;Bone Marrow Transplantation;2022-03-24